SO
53
-4
HAS
33
3
BA
54
5
SNA
68
-2
NVDA
56
-4
SYK
64
-4
PYPL
54
2
AON
54
2
VTR
47
-7
WM
79
3
PFE
23
7
F
58
11
BAC
53
3
PPL
54
-5
SCHW
62
-2
NWL
53
3
AA
48
-12
R
71
4
PBI
69
4
KMB
39
2
SO
53
-4
HAS
33
3
BA
54
5
SNA
68
-2
NVDA
56
-4
SYK
64
-4
PYPL
54
2
AON
54
2
VTR
47
-7
WM
79
3
PFE
23
7
F
58
11
BAC
53
3
PPL
54
-5
SCHW
62
-2
NWL
53
3
AA
48
-12
R
71
4
PBI
69
4
KMB
39
2
Financhill
Back

Kairos Pharma Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14

KAPA
Kairos Pharma

Last Price:
1.61
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Kairos Pharma Price Quote

$1.61
+0.01 (+7.33%)
(Updated: November 23, 2024 at 3:48 PM ET)

Kairos Pharma Key Stats

Sell
14
Kairos Pharma (KAPA) is a Sell
Day range:
$1.41 - $1.87
52-week range:
$1.22 - $4.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
255.5K
Avg. volume:
508.2K
1-year change:
0%
Market cap:
$20.5M
Revenue:
$0
EPS:
$-0.19

How Much Does Kairos Pharma Make?

Data Unavailable

Is Kairos Pharma Growing As A Company?

Data Unavailable

Kairos Pharma Stock Price Performance

  • Did Kairos Pharma Stock Go Up Last Month?
    Kairos Pharma share price went up by 10.34% last month
  • Did KAPA's Share Price Rise Over The Last Year?
    KAPA share price rose by 0% over the past 1 year

What Is Kairos Pharma 52-Week High & Low?

Kairos Pharma Price To Free Cash Flow

Is It Risky To Buy Kairos Pharma?

  • How Much Debt Does Kairos Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Kairos Pharma Have?
    Cash and short term investments quarterly total is $21K
  • What Is Kairos Pharma’s Book Value Per Share?
    Book value per share is -0.07

Is Kairos Pharma Cash Flow Positive?

  • What Is KAPA Cash Flow From Operations?
    Cash flow from operations (TTM) is $25K
  • What Is Kairos Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$236K
  • What Is Kairos Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Kairos Pharma Return On Invested Capital

Data Unavailable

Kairos Pharma Earnings Date & Stock Price

  • What Is Kairos Pharma's Stock Price Today?
    A single share of KAPA can be purchased today for 1.60
  • What Is Kairos Pharma’s Stock Symbol?
    Kairos Pharma trades on the nyam under the ticker symbol: KAPA
  • When Is Kairos Pharma’s Next Earnings Date?
    The next quarterly earnings date for Kairos Pharma is scheduled on November 29, 2024
  • When Is KAPA's next ex-dividend date?
    Kairos Pharma's next ex-dividend date is November 24, 2024
  • How To Buy Kairos Pharma Stock?
    You can buy Kairos Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Kairos Pharma Competitors

  • Who Are Kairos Pharma's Competitors?
    Below is a list of companies who compete with Kairos Pharma or are related in some way:
    • Bicara Therapeutics Inc (BCAX)
    • Bioage Labs Inc (BIOA)
    • Humana Inc (HUM)
    • TFF Pharmaceuticals Inc (TFFP)
    • Zenas BioPharma Inc (ZBIO)

Kairos Pharma Dividend Yield

Kairos Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -400%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 9.00
Upside from Last Price: 462.5%

Major Shareholders

Data Unavailable